Gabapentin Dosing in Adults
Gabapentin (Neurontin) dosing depends on the indication. It has non-linear (saturable) absorption - as the dose increases, the fraction absorbed decreases - which is why it's given in divided doses and titrated gradually.
1. Epilepsy (adjunctive therapy for focal/partial seizures)
- Start: 300 mg on day 1, titrating up over the first few days (or per some regimens, starting at 900 mg/day in 3 divided doses)
- Usual maintenance: 900-1800 mg/day in 3 divided doses
- Maximum: up to 3600 mg/day if higher doses are needed for seizure control
- Source: Goodman & Gilman's Pharmacological Basis of Therapeutics; Katzung's Basic and Clinical Pharmacology, 16th Ed.
2. Neuropathic Pain (postherpetic neuralgia, diabetic neuropathy, other neuropathic pain syndromes)
- Start: 100-300 mg at bedtime
- Titrate carefully upward over days to weeks (commonly to 3 times daily dosing)
- Effective/maintenance range: up to 3600 mg/day, well tolerated in most patients when titrated slowly
- Gabapentin is considered a first-line co-analgesic for neuropathic pain, particularly favored in elderly and medically ill patients because of its favorable safety profile and low drug-interaction potential
- Source: Bradley and Daroff's Neurology in Clinical Practice; Kaplan & Sadock's Comprehensive Textbook of Psychiatry (typical regimens use doses "at least" effective at creatinine clearance ≥60 mL/min, with reduction based on renal function)
3. Uremic Pruritus (dialysis patients) - special population dosing
- 100-300 mg given thrice weekly, after each dialysis session (not daily) - a much lower dose because gabapentin is renally cleared and accumulates in ESKD, risking neurotoxicity
- Source: Comprehensive Clinical Nephrology, 7th Edition
Renal Impairment - critical adjustment
Gabapentin is eliminated almost entirely unchanged by the kidneys and has a narrow therapeutic window in renal impairment. Dose must be reduced based on creatinine clearance in any patient with reduced renal function, and even more so in dialysis-dependent patients (dosed after dialysis only). Failure to adjust can cause accumulation and neurotoxic effects (sedation, myoclonus, encephalopathy).
Key practical points
- Divide total daily dose into 3 doses/day for most indications (except pruritus, which is post-dialysis dosing).
- Titrate slowly to minimize dizziness, somnolence, and unsteadiness - the most common adverse effects.
- Always individualize based on renal function, indication, and tolerability rather than jumping straight to high doses.
Note on evidence currency: A 2025 systematic review flagged potential cardiovascular safety signals (VTE, arrhythmia risk) with gabapentinoids (PMID: 40536375), and gabapentin misuse/dependence has drawn increasing clinical attention - worth considering in patients with cardiovascular risk factors or substance use history, though this doesn't change the standard dosing above.
This is general reference information from pharmacology and clinical textbooks - actual prescribing should be individualized by a clinician based on the patient's specific condition, renal function, and comorbidities.